drugset / Trial / NCT04561375

Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery

NCT04561375

Phase 4 Terminated 61 enrolled The Cleveland Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

A pilot study to evaluate the effect of incorporating sublingual sufentanil into our perioperative opioid regimen for ambulatory orthopedic surgery.

Timeline

Start
2020-12-11
Primary completion
2022-07-01
Completion
2022-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 50 ug
Comparator Sufentanil Other / unclassified 30 ug Other

Indications

No indication recorded.